Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.
The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.
Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

header-bg

Student Profiles

Background Header
Image
subpage

1 Search Results

student img

Sooraj Achar

Scholar Type:

NIH Oxford Scholar

Entry Year: 2020
Degrees:

B.S. Biochemistry, University of Virginia

Mentors:

Dr. Gregoire Altan-Bonnet (NCI)
and Prof. Mike Dustin (Oxford)

Research Interest:

Immunology, Computational and systems biology, Cancer Biology

As an undergraduate at the University of Virginia, Sooraj performed computational biology research under the supervision of Professor Cameron Mura. His research in Professor Mura’s group involved using molecular dynamics simulations to gain a better understanding of the kinetics of protein-RNA binding interactions in bacterial RNA chaperones. He also conducted research at the NIDDK with Dr. Caroline Philpott, where he analyzed the interaction dynamics of two cytosolic mammalian iron chaperones using immunoprecipitation assays and molecular docking. Upon graduation, Sooraj joined the laboratory of Dr. Gregoire Altan-Bonnet at the NCI as an NIH post baccalaureate fellow, where his project focused on deconvolving the effects of the quality (TCR binding affinity) and quantity (surface density) of an antigen on T cell activation. During the course of this research project, Sooraj developed and optimized a robotic platform and data processing pipeline to allow for high time resolution measurements of many aspects of T cell activation dynamics. In his doctoral research project, he aims to combine these robotics-based temporal measurements with microscopy-based spatial measurements of immune cell activation to gain a holistic understanding of how T cell activation is governed by antigen quality. His eventual goal is to apply these techniques to analyze CAR-T cell activation to produce more robust pre-clinical metrics for assessing immunotherapy efficacy.

N/A
Back to Top